Asundexian

N/A

Report date: 2026/05/22 16:38:39
NME

Base Information

Drug NameAsundexian
Drug Alias NameBAY-2433334
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIa inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsIschemic StrokeThromboembolismEmbolism +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[42
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsIschemic StrokeThromboembolismMyocardial Infarction +[6
Inactive IndicationsEmbolismAtrial Fibrillation

Other Information

ATC CodeN/A
Related LinksN/A